The outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice

Mount, Peter F., Gleich, Kurt, Tam, Shanna, Fraser, Scott A., Choy, Suet-Wan, Dwyer, Karen M., Lu, Bo, Van Denderen, Bryce, Fingerle-Rowson, Günter, Bucala, Richard, Kemp, Bruce E. and Power, David A. 2012, The outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice, PLoS One, vol. 7, no. 1, pp. e29887, doi: 10.1371/journal.pone.0029887.

Attached Files
Name Description MIMEType Size Downloads

Title The outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice
Author(s) Mount, Peter F.
Gleich, Kurt
Tam, Shanna
Fraser, Scott A.
Choy, Suet-Wan
Dwyer, Karen M.ORCID iD for Dwyer, Karen M.
Lu, Bo
Van Denderen, Bryce
Fingerle-Rowson, Günter
Bucala, Richard
Kemp, Bruce E.
Power, David A.
Journal name PLoS One
Volume number 7
Issue number 1
Start page e29887
Total pages 10
Publisher Public Library of Science
Place of publication San Francisco, Calif.
Publication date 2012-01
ISSN 1932-6203
Keyword(s) AMP-Activated Protein Kinases
Enzyme Activation
Macrophage Migration-Inhibitory Factors
Reperfusion Injury
Summary AIM: Activation of the master energy-regulator AMP-activated protein kinase (AMPK) in the heart reduces the severity of ischemia-reperfusion injury (IRI) but the role of AMPK in renal IRI is not known. The aim of this study was to determine whether activation of AMPK by acute renal ischemia influences the severity of renal IRI. METHODS: AMPK expression and activation and the severity of renal IRI was studied in mice lacking the AMPK β1 subunit and compared to wild type (WT) mice. RESULTS: Basal expression of activated AMPK, phosphorylayed at αThr¹⁷², was markedly reduced by 96% in AMPK-β1⁻/⁻ mice. Acute renal ischaemia caused a 3.2-fold increase in α1-AMPK activity and a 2.5-fold increase in α2-AMPK activity (P<0.001) that was associated with an increase in AMPK phosphorylation of the AMPK-α subunit at Thr¹⁷² and Ser⁴⁸⁵, and increased inhibitory phosphorylation of the AMPK substrate acetyl-CoA carboxylase. After acute renal ischemia AMPK activity was reduced by 66% in AMPK-β1⁻/⁻ mice compared with WT. There was no difference, however, in the severity of renal IRI at 24-hours between AMPK-β1⁻/⁻ and WT mice, as measured by serum urea and creatinine and histological injury score. In the heart, macrophage migration inhibitory factor (MIF) released during IRI contributes to AMPK activation and protects from injury. In the kidney, however, no difference in AMPK activation by acute ischemia was observed between MIF⁻/⁻ and WT mice. Compared with the heart, expression of the MIF receptor CD74 was found to be reduced in the kidney. CONCLUSION: The failure of AMPK activation to influence the outcome of IRI in the kidney contrasts with what is reported in the heart. This difference might be due to a lack of effect of MIF on AMPK activation and lower CD74 expression in the kidney.
Language eng
DOI 10.1371/journal.pone.0029887
Field of Research MD Multidisciplinary
Copyright notice ©2012, The Authors
Persistent URL

Document type: Journal Article
Collections: School of Medicine
Open Access Checking
Elements - New records (hidden)
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 17 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 5 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Tue, 10 Jul 2018, 10:44:18 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact